Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study.
暂无分享,去创建一个
S. Vukusic | D. Laplaud | G. Kobelt | P. Labauge | D. Pau | J. Grouin | É. Manchon | Thibault Moreau | M. Lotz | Lebrun Christine